These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8674003)

  • 1. Prognostic value of immunohistochemically detected CD44 expression in patients with carcinoma of the vulva.
    Tempfer C; Gitsch G; Haeusler G; Reinthaller A; Koelbl H; Kainz C
    Cancer; 1996 Jul; 78(2):273-7. PubMed ID: 8674003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the adhesion molecule CD44v3 is a prognostic factor in vulvar carcinoma.
    Tempfer C; Gitsch G; Hanzal E; Reinthaller A; Koelbl H; Kainz C
    Anticancer Res; 1996; 16(4A):2029-31. PubMed ID: 8712738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splice variants of CD44 in human cervical cancer stage IB to IIB.
    Kainz C; Kohlberger P; Sliutz G; Tempfer C; Heinzl H; Reinthaller A; Breitenecker G; Koelbl H
    Gynecol Oncol; 1995 Jun; 57(3):383-7. PubMed ID: 7539775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD44v3 and v6 variant isoform expression correlates with poor prognosis in early-stage vulvar cancer.
    Tempfer C; Sliutz G; Haeusler G; Speiser P; Reinthaller A; Breitenecker G; Vavra N; Kainz C
    Br J Cancer; 1998 Oct; 78(8):1091-4. PubMed ID: 9792156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble CD44 standard, CD44 variant 5 and CD44 variant 6 and their relation to staging in head and neck cancer.
    Kawano T; Yanoma S; Nakamura Y; Ozeki A; Kokatsu T; Kubota A; Furukawa M; Tsukuda M
    Acta Otolaryngol; 2005 Apr; 125(4):392-7. PubMed ID: 15823810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy.
    Noordzij MA; van Steenbrugge GJ; Verkaik NS; Schröder FH; van der Kwast TH
    Clin Cancer Res; 1997 May; 3(5):805-15. PubMed ID: 9815753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 protein expression in squamous cell carcinoma of the vulva.
    Scheistrøen M; Tropé C; Pettersen EO; Nesland JM
    Cancer; 1999 Mar; 85(5):1133-8. PubMed ID: 10091798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
    Nguyen VN; Mirejovský T; Melinová L; Mandys V
    Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor.
    Hirata T; Fukuse T; Naiki H; Hitomi S; Wada H
    Cancer Res; 1998 Mar; 58(6):1108-10. PubMed ID: 9515789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of CD44 expression in invasive squamous cell carcinoma of the vulva.
    Rodríguez-Rodríguez L; Sancho-Torres I; Miller Watelet L; Gibbon DG; Comerci JT; Mesonero C
    Gynecol Oncol; 1999 Oct; 75(1):34-40. PubMed ID: 10502422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of CD44 isoform expression in thymic epithelial neoplasms.
    Sonobe S; Miyamoto H; Nobukawa B; Izumi H; Futagawa T; Ishikawa N; Yamazaki A; Uekusa T; Abe H; Suda K
    Cancer; 2005 May; 103(10):2015-22. PubMed ID: 15830350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and prognostic value of the CD44 splicing variants v5 and v6 in gastric cancer.
    Müller W; Schneiders A; Heider KH; Meier S; Hommel G; Gabbert HE
    J Pathol; 1997 Oct; 183(2):222-7. PubMed ID: 9390037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer.
    Friedrichs K; Franke F; Lisboa BW; Kügler G; Gille I; Terpe HJ; Hölzel F; Maass H; Günthert U
    Cancer Res; 1995 Nov; 55(22):5424-33. PubMed ID: 7585612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck.
    Herold-Mende C; Seiter S; Born AI; Patzelt E; Schupp M; Zöller J; Bosch FX; Zöller M
    J Pathol; 1996 May; 179(1):66-73. PubMed ID: 8691348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vulvar squamous cell carcinoma. Prognostic factors for local recurrence after primary en bloc radical vulvectomy and bilateral groin dissection.
    Fonseca-Moutinho JA; Coelho MC; Silva DP
    J Reprod Med; 2000 Aug; 45(8):672-8. PubMed ID: 10986688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of adhesion molecule CD44 splice variants in lymph node metastases of cervical cancer.
    Kainz C; Tempfer C; Kohlberger P; Janisch S; Koelbl H; Gitsch G; Breitenecker G
    Int J Cancer; 1996 Jun; 69(3):170-3. PubMed ID: 8682582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of CD44 molecule in renal cell carcinoma.
    Lucin K; Matusan K; Dordević G; Stipić D
    Croat Med J; 2004 Dec; 45(6):703-8. PubMed ID: 15578803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of CD44 variant isoforms by cell lines and tissue specimens of transitional cell carcinomas.
    Chuang CK; Liao SK
    Anticancer Res; 2003; 23(6C):4635-9. PubMed ID: 14981907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of CD44v6-containing isoforms during proliferation of normal and malignant epithelial cells.
    Soukka T; Salmi M; Joensuu H; Häkkinen L; Sointu P; Koulu L; Kalimo K; Klemi P; Grénman R; Jalkanen S
    Cancer Res; 1997 Jun; 57(11):2281-9. PubMed ID: 9187133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered CD44 variant 6 expression in FIGO stage IB cervical carcinoma.
    Ayhan A; Baykal C; Al A; Ayhan A
    Gynecol Oncol; 2001 Dec; 83(3):569-74. PubMed ID: 11733974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.